The Content
Agency for Healthcare Research and Quality (AHRQ) - Advancing Excellence in Health Care US Department of Health and Human Services - Improving the health, safety, and well-being of America
AHRQ 2011 Publications Online Store - ahrqpubs.ahrq.gov
Online Store Home Page FAQs
       
         		Cart
Cart		    Profile
Profile		   
Login		    Register
Register		       
 
       Advanced Search
Back to Top
  
Online Store Home Page >  Evidence Report/Technology Assessment

  Evidence Report/Technology Assessment

Alternative OrderingPhone: 1-800-358-9295; Outside of the United States: 703-437-2078; TTY/TDD: 1-888-586-6340
Mail: AHRQ Publications Clearinghouse, P.O. Box 8547, Silver Spring, MD 20907-8547
 
  Abdominal Aortic Aneurysm, Endovascular and Open Surgical Repairs. AHRQ 06-E017
Evidence Report/Technology Assessment No. 144. Evidence Report. August 2006  
 
Product Cost:  $0.00   EACH
 
  Adnexal Mass, Management. AHRQ 06-E004
Evidence Report/Technology Assessment No. 130. Evidence Report. January 2006  
 
Product Cost:  $0.00   EACH
 
  Angina, Unstable, Prediction of Risk for Patients. AHRQ 01-E001
Evidence Report/Technology Assessment No. 31. Evidence Report. December 2000  
 
Product Cost:  $0.00   EACH
 
  Angina, Unstable, Prediction of Risk for Patients. AHRQ00-E030
Evidence Report/Technology Assessment No. 31. Summary. August 2000  
 
Product Cost:  $0.00   EACH
 
  Antioxidant Supplements, Prevention and Treatment of Cancer. AHRQ 04-E002
Evidence Report/Technology Assessment No. 75. Summary. October 2003  
 
Product Cost:  $0.00   EACH
 
  Antioxidant Supplements, Prevention and Treatment of Cancer. AHRQ 04-E003
Evidence Report/Technology Assessment No. 75. Evidence Report. October 2003  
 
Product Cost:  $0.00   EACH
 
  Antioxidant Supplements, Prevention and Treatment of Cardiovascular Disease. AHRQ03-E042
Evidence Report/Technology Assessment No. 83. Summary. June 2003  
 
Product Cost:  $0.00   EACH
 
  Antioxidant Supplements, Prevention and Treatment of Cardiovascular Disease. AHRQ03-E043
Evidence Report/Technology Assessment No. 83. Evidence Report. July 2003  
 
Product Cost:  $0.00   EACH
 
  Antiretroviral Drug Resistance in the Developing World AHRQ 07-E014
Evidence Report/Technology Assessment No. 156. July 2007. Identifies critical gaps in the published research regarding the development of ARV resistance in developing countries and identify issues for clinicians rolling out HIV medications in the developing world.  
 
Product Cost:  $0.00   EACH
 
  Asthma, Work-Related, Diagnosis and Management. AHRQ 06-E003-1
Evidence Report/Technology Assessment No. 129. Summary. October 2005  
 
Product Cost:  $0.00   EACH
 
  Asthma, Work-Related, Diagnosis and Management. AHRQ 06-E003-2
Evidence Report/Technology Assessment No. 129. Evidence Report. November 2005  
 
Product Cost:  $0.00   EACH
 
  Atrial Fibrillation, Management of New Onset. AHRQ 01-E026
Evidence Report/Technology Assessment No. 12. Evidence Report. January 2001  
 
Product Cost:  $0.00   EACH
 
  Atrial Fibrillation, Management of New Onset. AHRQ00-E006
Evidence Report/Technology Assessment No. 12. Summary. May 2000  
 
Product Cost:  $0.00   EACH
 
  Attention-Deficit/Hyperactivity Disorder, Treatment. AHCPR99-E017
Evidence Report/Technology Assessment No. 11. Summary. November 1999  
 
Product Cost:  $0.00   EACH
 
  Attention-Deficit/Hyperactivity Disorder, Treatment. AHRQ00-E005
Evidence Report/Technology Assessment No. 11. Evidence Report. November 1999  
 
Product Cost:  $0.00   EACH
 
  Autopsy. AHRQ03-E001
Evidence Report/Technology Assessment No. 58. Summary. October 2002  
 
Product Cost:  $0.00   EACH
 
  Autopsy. AHRQ03-E002
Evidence Report/Technology Assessment No. 58. Evidence Report. October 2002  
 
Product Cost:  $0.00   EACH
 
  B Vitamins and Berries and Age-Related Neurodegenerative Disorders AHRQ 06-E008
Evidence Report/Technology Assessment No. 134. Evidence Report. April 2006  
 
Product Cost:  $0.00   EACH
 
  Bariatric Surgery in Women of Reproductive Age: Special Concerns for Pregnancy AHRQ 08-E013
Evidence Report/Technology Assessment No. 169. September 2008. Measures the incidence of bariatric surgery in women of reproductive age and review the evidence on the impact of bariatric surgery on fertility and subsequent pregnancy.  
 
Product Cost:  $0.00   EACH
 
  Barriers and Drivers of Health Information Technology Use for the Elderly, Chronically Ill, and Underserved. AHRQ 09-E004
Evidence Report/Technology Assessment No. 175, November 2008. This report describes factors influencing the use, usefulness, and usability of interactive consumer health IT for elderly, chronically ill, and underserved populations.  
 
Product Cost:  $0.00   EACH
 
  Bioterrorism Preparedness, Information Technology. AHRQ02-E027
Evidence Report/Technology Assessment No. 59. Summary. June 2002  
 
Product Cost:  $0.00   EACH
 
  Bioterrorism Preparedness, Information Technology. AHRQ02-E028
Evidence Report/Technology Assessment No. 59. Evidence Report. June 2002  
 
Product Cost:  $0.00   EACH
 
  Bioterrorism Preparedness, Pediatric Anthrax AHRQ 06-E013
Evidence Report/Technology Assessment No. 141. Evidence Report. July 2006  
 
Product Cost:  $0.00   EACH
 
  Bioterrorism Preparedness, Regionalization. AHRQ 04-E016-1
Evidence Report/Technology Assessment No. 96. Summary. April 2004  
 
Product Cost:  $0.00   EACH
 
  Bioterrorism Preparedness, Regionalization. AHRQ 04-E016-2
Evidence Report/Technology Assessment No. 96. Evidence Report. April 2004  
 
Product Cost:  $0.00   EACH

Previous 1 - 25 Next 25
  
Welcome
Guest
Login

Register

View Shopping Cart
No items

View Saved Carts

View Shopping Lists


AHRQ - Advancing Excellence in Health Care